AXTOB-F
COMPOSITION:- Tobramycin 0.3% + Flurometholone 0.1% W/V
PACKAGE:- 5ml
Devaksh Lifesciences introduces AXTOB-F, a safety-optimized combination that is created to target patients who need to be provided with the balanced anti-inflammatory and antibiotic treatment. It is a formulation that incorporates the reliability of the efficacy of Tobramycin coupled with Fluorometholone, a steroid with a safe-profile. Fluorometholone offers good topical inflammation and much lower the chances of increasing intraocular pressure (IOP). This renders AXTOB-F a perfect long-term therapy of treating delicate or chronic inflammatory disorders without jeopardizing the state of the optic nerve.
Key Features:
- Has a low propensity steroid that is of the safety-first type.
- Strong aminoglycoside effect prevents and treats shallow bacterial development.
- Particularly affects the conjunctiva and the corneal surface to provide local relief.
- A fine suspension guarantees a sting free application.
Benefits & Advantages:
- Best in patients who are steroid responders or at a greater risk of Glaucoma.
- Successfully treats itching, burning and allergic inflammatory exacerbations.
- Minimizes the chances of complications caused by steroids in long-term courses.
- Ensures the wound on the eyelid and cornea is kept clean and free of the infection.
Usage & Clinical Highlights:
- Aimed at patients who have chronic Blepharitis and eyelid inflammation.
- Indicated in steroid responsive bacterially-at-risk inflammatory diseases.
- Useful in the treatment of seasonal allergic conjunctivitis of secondary infection.
- Clinically preferred in the post LASIK care where pressure is imperative.
- Can be used safely in adults and children (above 2 years) with the medical supervision.
